Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: The Fremantle Diabetes Study Phase II

被引:15
|
作者
Davis, Timothy M. E. [1 ]
Hunt, Kerry [1 ]
Bruce, David G. [1 ]
Starkstein, Sergio [2 ]
Skinner, Timothy [3 ]
McAullay, Daniel [4 ,5 ]
Davis, Wendy A. [1 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA 6959, Australia
[2] Univ Western Australia, Sch Psychiat & Clin Neurosci, Fremantle Hosp, Fremantle, WA 6959, Australia
[3] Charles Darwin Univ, Sch Psychol & Clin Sci, Casuarina, NT, Australia
[4] Edith Cowan Univ, Kurongkurl Katitjin Ctr Indigenous Australian Edu, Mt Lawley, WA, Australia
[5] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia
基金
英国医学研究理事会;
关键词
Type; 2; diabetes; Depression; Aboriginal; Antidepressant treatment; Metabolic control; INDIGENOUS AUSTRALIAN POPULATIONS; SCREENING TOOL; HEALTH; RISK; COMPLICATIONS; DETERMINANTS; VALIDITY; ALCOHOL; PROFILE; PEOPLE;
D O I
10.1016/j.diabres.2014.12.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To determine the prevalence and associates of depression in Aboriginal and Anglo-Celt (AC) Australians with type 2 diabetes. Methods: Community-based patients were screened using the Patient Health Questionnaire (PHQ-9) as part of detailed assessment. The prevalence of any current depression, major depression and antidepressant use by racial group was compared after adjustment for age, sex, educational attainment and marital status. Multiple logistic regression was used to determine associates of current depression. Results: The 107 Aboriginal participants were younger (mean +/- SD 54.3 +/- 11.8 vs 67.2 +/- 10.6 years), less often male (34.6% vs 50.9%) and married (39.3% vs 61.7%), and more likely to smoke (44.6% vs 8.1%) than the 793 AC subjects (P <= 0.002). Fifty-two Aboriginal (48.5%) and 772 AC participants (97.4%) completed the PHQ-9; these Aboriginals had similar socio-demographic, anthropometric and diabetes-related characteristics to those without PHQ-9 data. A quarter of the Aboriginals had current depression vs 10.6% of ACs (P = 0.16), 15.4% vs 4.1% had major depression (P = 0.029), and 68.8% vs 29.7% had untreated depression (P = 0.032). Compared with non-depressed participants, patients with current depression were younger and more likely to smoke, to be overweight/obese and to have worse glycaemic control (P <= 0.024). Significant independent associates of current depression were educational attainment (inversely), smoking status, body mass index and fasting plasma glucose in the AC group and alcohol use in the Aboriginal group. Conclusions: Although prevalence of depression was not significantly increased in the Aboriginal patients, it was more likely to be major and untreated. Depression complicating type 2 diabetes is associated with adverse cardiovascular risk. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:384 / 391
页数:8
相关论文
共 50 条
  • [1] Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: the Fremantle Diabetes Study Phase II
    Drinkwater, Jocelyn J.
    Davis, Wendy A.
    Turner, Angus W.
    McAullay, Daniel
    Davis, Timothy M. E.
    INTERNAL MEDICINE JOURNAL, 2022, 52 (04) : 590 - 598
  • [2] Continuing Disparities in Cardiovascular Risk Factors and Complications Between Aboriginal and Anglo-Celt Australians With Type 2 Diabetes The Fremantle Diabetes Study
    Davis, Timothy M. E.
    Hunt, Kerry
    McAullay, Daniel
    Chubb, Stephen A. P.
    Sillars, Brett A.
    Bruce, David G.
    Davis, Wendy A.
    DIABETES CARE, 2012, 35 (10) : 2005 - 2011
  • [3] Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study
    Davis, Wendy A.
    Chin, Eunice
    Jee, Adelle
    Martins, Jen
    Bruce, David G.
    Beilby, John
    Davis, Timothy M. E.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 163 (04) : 559 - 564
  • [4] Prevalence of autoimmune diabetes among Aboriginal Australians: the Fremantle Diabetes Study Phase II
    Davis, Timothy M. E.
    Bundell, Christine S.
    Chubb, Stephen A. Paul
    Mcaullay, Daniel
    Davis, Wendy A.
    INTERNAL MEDICINE JOURNAL, 2025, : 659 - 663
  • [5] COMORBID ANXIETY AND DEPRESSION AND THEIR IMPACT ON CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: THE FREMANTLE DIABETES STUDY PHASE II
    Bruce, David G.
    Davis, Wendy A.
    Dragovic, Milan
    Davis, Timothy M. E.
    Starkstein, Sergio E.
    DEPRESSION AND ANXIETY, 2016, 33 (10) : 960 - 966
  • [6] Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    DIABETES OBESITY & METABOLISM, 2018, 20 (12) : 2852 - 2859
  • [7] Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II
    Peters, Kirsten E.
    Chubb, Stephen A. Paul
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    CLINICAL ENDOCRINOLOGY, 2020, 92 (04) : 373 - 382
  • [8] Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase II
    Yarash, Tatsiana
    Sharif, Imrana
    Masood, Farhat
    Clifford, Rhonda M.
    Davis, Wendy A.
    Davis, Timothy M. E.
    INTERNAL MEDICINE JOURNAL, 2020, 50 (08) : 944 - 950
  • [9] A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study
    Bruce, DG
    Davis, WA
    Starkstein, SE
    Davis, TME
    DIABETOLOGIA, 2005, 48 (12) : 2532 - 2539
  • [10] Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II
    Drinkwater, Jocelyn J.
    Davis, Timothy M. E.
    Turner, Angus W.
    Davis, Wendy A.
    DIABETIC MEDICINE, 2023, 40 (04)